Texas Money Saddles Up in San Francisco: Why Lone Star Investors Are Betting Big on Union Square

Texas investors illustration

San Francisco’s commercial real estate market has been through the wringer—but in a twist nobody saw coming, the cavalry has arrived from Texas. Investors from the Lone Star State are scooping up discounted buildings in Union Square and downtown SF, transforming the city’s post‑pandemic slump into a bargain‑hunter’s dream.

According to a recent report from The SF Standard, Texas capital is flowing into major commercial properties, including the seven‑story One Union Square building and potentially the massive 360,000‑square‑foot tower at 600 California Street—once a key part of WeWork’s empire. Dallas‑based Lone Star Funds is widely believed to be the buyer, though the company isn’t talking. Yet.

Why the Sudden Texas Invasion?

The answer lies in timing and opportunity. Derek Daniels, research director at Colliers, says San Francisco’s ongoing recovery has reignited national interest. The city’s once‑struggling “boom loop” is showing signs of life, and investors across the country are tuning in.

“As the recovery gains momentum, we’re seeing renewed interest from investors outside the region,” Daniels said. He credits Mayor Daniel Lurie for boosting confidence through consistent messaging that SF is back in business.

Union Square: From Ghost Town to Golden Opportunity

Once overshadowed by pandemic closures, Union Square is rapidly regaining traction thanks to rising office leasing activity and renewed foot traffic. Kelly Glass of Avison Young says a new wave of buyers is stepping in with enthusiasm.

“There’s a new investor pool focused on the area,” she said. “Whenever I speak to them, they’re like, ‘Oh, you’re getting us excited,’ because the volume is there.”

Not Just Texas: A Coast‑to‑Coast Buying Spree

New York investors, Alaskan groups, and buyers from Southern California have joined the surge, snapping up prime downtown assets. Uris Acquisitions alone has purchased three buildings along Powell Street since May.

Lacie Ravina, vice president at Colliers, puts it simply: “We’ve bottomed out, and investors know it’s time to acquire buildings at historic lows.”

What This Means for Real Estate Professionals

For real estate pros—whether in Florida, Texas, New York, or anywhere in the U.S.—San Francisco’s comeback is a masterclass in market cycles. Markets rarely stay down forever. The savviest investors understand how to spot a bottom, predict a rebound, and act boldly when others hesitate.

At Cameron Academy, we train aspiring and seasoned professionals to recognize these patterns, interpret trends, and make smart, informed decisions. Whether you’re pursuing or renewing a license in real estate, mortgage, insurance, finance, or other fields, education is—and always will be—your most powerful investment.

Explore More from the Source

For full details and continued coverage, visit the original article at The SF Standard.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The Remote Work Revolution: Redefining Real Estate

Imagine a morning where the commute is just a few steps from your bedroom to your home office. This is the reality for many in today's post-pandemic world, where remote work has become a staple of the modern workforce.

By |December 2, 2024|Categories: Article, Real Estate, Remote Work|Tags: , |0 Comments

CRISPR: The Future of Gene Editing and Its Clinical Implications

CRISPR technology has become the frontrunner in genome editing, surpassing earlier methods like zinc finger nucleases and transcription activator-like effector nucleases. The recent FDA approval of the CRISPR-Cas9 drug, exa-cel, marks a significant milestone particularly for treating sickle cell disease and transfusion-dependent beta thalassemia.

By |December 1, 2024|Categories: Article, Biotechnology, Medicine|Tags: , |0 Comments

AI Revolution in Oncology: Transformative Potential or Overhyped?

In recent years, artificial intelligence has emerged as a revolutionary tool in the field of oncology. AI's integration into healthcare transcends buzzwords, transforming cancer diagnosis, treatment personalization, and drug discovery.

AI in Radiology: A Double-Edged Sword

The rapid advancements in artificial intelligence (AI) are transforming the landscape of radiology, promising to enhance diagnostic accuracy and support personalized medicine. However, as this technology becomes more integral to medical imaging, it brings with it a host of ethical and societal considerations that cannot be ignored.

Humanity at the Crossroads: Ethical Implications of AI in Medicine

AI's promise in healthcare is undeniable, with its ability to uncover hidden disease patterns and predict illnesses. However, the reliance on historical data can exacerbate existing biases, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic and racial groups.

The Future of Telemedicine: Challenges and Opportunities Beyond the Pandemic

Telemedicine stands out as a transformative force, offering a lifeline to patients and providers alike. As we move beyond the pandemic, the challenge is to integrate this technology without escalating costs or overshadowing the indispensable role of in-person consultations.

By |November 30, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments